Puretech founded entity karuna therapeutics announces results from phase 1b trial evaluating the safety and tolerability of karxt in healthy elderly volunteers

Boston--(business wire)--puretech founded entity karuna announces results from phase 1b trial evaluating the safety and tolerability of karxt in healthy elderly volunteers

PRTC Ratings Summary

PRTC Quant Ranking